Piperacillin Sulfoxide
 
		Product Description
CAT No.
				
									ALN-P048014								
				CAS No.
				
									67275-27-8								
				Mol. F.
				
									C23H27N5O8S								
				Mol. Wt.
				
									533.6								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (2S,5R,6R)-6-((R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4-oxide								
				
									Smiles : O=C([C@@H](C1=CC=CC=C1)NC(N(CCN(CC)C2=O)C2=O)=O)N[C@H]3[C@]([S]4=O)([H])N([C@@H](C(O)=O)C4(C)C)C3=O								
				
									Inchi : InChI=1S/C31H37N7O9S2/c1-6-35-12-13-36(25(44)24(35)43)29(47)34-15(14-10-8-7-9-11-14)20(39)32-16-22(41)37-18(30(2,3)48-26(16)37)21(40)33-17-23(42)38-19(28(45)46)31(4,5)49-27(17)38/h7-11,15-19,26-27H,6,12-13H2,1-5H3,(H,32,39)(H,33,40)(H,34,47)(H,45,46)/t15-,16+,17-,18+,19+,26-,27-/m1/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Quantification of cefepime, meropenem, piperacillin, and tazobactam in human plasma using a sensitive and robust liquid chromatography-tandem mass spectrometry method, part 2: stability evaluation
									By D’cunha, Ronilda; Bach, Thanh; Young, Beth Ann; Li, Peizhi; Nalbant, Demet; Zhang, Jun; Winokur, Patricia; An, GuohuanFrom Antimicrobial Agents and Chemotherapy (2018), 62(9), e00861-18/1-e00861-18/9								
				Stability indicating RP-HPLC method for the determination of Piperacillin and Tazobactam and their related substances in bulk and pharmaceutical formulation
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            